Contrast-enhanced and unenhanced diffusion-weighted imaging of the breast at 3 T

M Fanariotis, I Tsougos, M Vlychou, I Fezoulidis… - Clinical Radiology, 2018 - Elsevier
Aim To evaluate the effect of intravenous gadolinium contrast agent on diffusion-weighted
sequences and apparent diffusion coefficient (ADC) measurements at 3 T. Materials and …

Contrast-enhanced and unenhanced diffusion-weighted imaging of the breast at 3 T.

M Fanariotis, I Tsougos, M Vlychou, I Fezoulidis… - Clinical …, 2018 - europepmc.org
Aim To evaluate the effect of intravenous gadolinium contrast agent on diffusion-weighted
sequences and apparent diffusion coefficient (ADC) measurements at 3 T. Materials and …

Contrast-enhanced and unenhanced diffusion-weighted imaging of the breast at 3 T

M Fanariotis, I Tsougos, M Vlychou… - Clinical …, 2018 - clinicalradiologyonline.net
Aim To evaluate the effect of intravenous gadolinium contrast agent on diffusion-weighted
sequences and apparent diffusion coefficient (ADC) measurements at 3 T. Materials and …

Contrast-enhanced and unenhanced diffusion-weighted imaging of the breast at 3 T

M Fanariotis, I Tsougos, M Vlychou… - Clinical …, 2018 - pubmed.ncbi.nlm.nih.gov
Aim To evaluate the effect of intravenous gadolinium contrast agent on diffusion-weighted
sequences and apparent diffusion coefficient (ADC) measurements at 3 T. Materials and …

Contrast-enhanced and unenhanced diffusion-weighted imaging of the breast at 3 T

M Fanariotis, I Tsougos, M Vlychou, I Fezoulidis… - 2018 - ir.lib.uth.gr
Aim: To evaluate the effect of intravenous gadolinium contrast agent on diffusion-weighted
sequences and apparent diffusion coefficient (ADC) measurements at 3 T. Materials and …